BRIEF published on 04/11/2025 at 20:05, 9 months 23 days ago Oxurion Publie son Rapport Annuel 2024 et Convoque son Assemblée Générale Déclarations Prospectives Rapport Annuel 2024 Oxurion NV Thérapies Ophtalmologiques Assemblées Actionnaires
BRIEF published on 04/11/2025 at 20:05, 9 months 23 days ago Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
PRESS RELEASE published on 04/11/2025 at 20:05, 9 months 23 days ago Publication Annual Report - Annual Shareholders' Meeting Oxurion NV releases its annual report for the financial year 2024 and convenes its Annual Shareholders' Meeting in Leuven, Belgium. Developing ophthalmic therapies for retinal disease Shareholders' Meeting Annual Report Ophthalmic Therapies Oxurion NV Retinal Disease
PRESS RELEASE published on 04/11/2025 at 20:00, 9 months 23 days ago Publicatie jaarverslag - Jaarlijkse Algemene Vergadering Oxurion NV publice son rapport annuel 2024, convoque son assemblée annuelle d'actionnaires et se concentre sur les thérapies ophtalmologiques Rapport Annuel 2024 Oxurion NV Assemblée Annuelle Thérapies Ophtalmologiques Biofarmaceutique
BRIEF published on 04/04/2025 at 14:05, 10 months ago Report de l'Assemblée Générale d'Oxurion Assemblée Générale Biopharmaceutique Report Oxurion Thérapies Ophtalmologiques
BRIEF published on 04/04/2025 at 14:05, 10 months ago Oxurion General Meeting Postponed General Meeting Biopharmaceuticals Report Ophthalmic Therapies Oxurion
PRESS RELEASE published on 04/04/2025 at 14:00, 10 months ago Uitstel Gewone Algemene Vergadering Oxurion NV annonce le report de son Assemblée Générale des Actionnaires au 13 mai 2025 en raison de l'indisponibilité de ses états financiers Assemblée Générale États Financiers Report Risques Oxurion NV
PRESS RELEASE published on 04/04/2025 at 14:00, 10 months ago Postponement Annual Shareholders Meeting Oxurion NV postponed its Annual Shareholders Meeting to May 13, 2025, due to pending annual accounts. The biopharmaceutical company, focused on ophthalmic therapies, is based in Leuven, Belgium Biopharmaceutical Annual Shareholders Meeting Postponed Ophthalmic Therapies Oxurion NV
BRIEF published on 04/02/2025 at 18:05, 10 months 2 days ago Oxurion reçoit une notification de transparence de Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Biopharmacie
BRIEF published on 04/02/2025 at 18:05, 10 months 2 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Biopharmacy
Published on 02/05/2026 at 01:35, 2 hours 9 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 3 hours 44 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 5 hours 19 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 11 hours 29 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 6 hours 50 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 7 hours 8 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 7 hours 44 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 8 hours 49 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 9 hours 4 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 9 hours 40 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 9 hours 40 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 9 hours 59 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 9 hours 59 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
